Positron Emission Tomography Imaging of Cancer Biology: Current Status and Future Prospects

被引:99
作者
Chen, Kai [1 ]
Chen, Xiaoyuan [2 ]
机构
[1] Univ So Calif, Keck Sch Med, Mol Imaging Ctr, Dept Radiol, Los Angeles, CA 90033 USA
[2] Natl Inst Biomed Imaging & Bioengn, Lab Mol Imaging & Nanomed, NIH, Bethesda, MD 20892 USA
关键词
GROWTH-FACTOR RECEPTOR; INTEGRIN ALPHA(V)BETA(3) EXPRESSION; SQUAMOUS-CELL CARCINOMA; GLUCOSE METABOLIC-RATE; PROLIFERATION IN-VIVO; BREAST-CANCER; TUMOR HYPOXIA; QUANTITATIVE PET; ANNEXIN-V; ALPHA(V)-INTEGRIN EXPRESSION;
D O I
10.1053/j.seminoncol.2010.11.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Positron emission tomography (PET) is one of the most rapidly growing areas of medical imaging, with many applications in the clinical management of patients with cancer. The principal goal of PET imaging is to visualize, characterize, and measure biological processes at the cellular, subcellular, and molecular levels in living subjects using noninvasive procedures. PET imaging takes advantage of the traditional diagnostic imaging techniques and introduces positron-emitting probes to determine the expression of indicative molecular targets at different stages of cancer progression. Although [ 18F]fluorodeoxyglucose ([18F]FDG)-PET has been widely utilized for staging and restaging of cancer, evaluation of response to treatment, differentiation of post-therapy alterations from residual or recurrent tumor, and assessment of prognosis, [18F]FDG is not a target-specific PET tracer. Over the last decade, numerous target-specific PET tracers have been developed and evaluated in preclinical and clinical studies. This review provides an overview of the current status and trends in the development of non-[18F]FDG PET probes in oncology and their application in the investigation of cancer biology. © 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:70 / 86
页数:17
相关论文
共 126 条
[1]
Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis [J].
Almutairi, Adah ;
Rossin, Raffaella ;
Shokeen, Monica ;
Hagooly, Aviv ;
Ananth, Ashwin ;
Capoccia, Benjamin ;
Guillaudeu, Steve ;
Abendschein, Dana ;
Anderson, Carolyn J. ;
Welch, Michael J. ;
Frechet, Jean M. J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (03) :685-690
[2]
Anderson CJ, 2001, J NUCL MED, V42, P213
[3]
ARG-GLY-ASP CONSTRAINED WITHIN CYCLIC PENTAPEPTIDES - STRONG AND SELECTIVE INHIBITORS OF CELL-ADHESION TO VITRONECTIN AND LAMININ FRAGMENT-P1 [J].
AUMAILLEY, M ;
GURRATH, M ;
MULLER, G ;
CALVETE, J ;
TIMPL, R ;
KESSLER, H .
FEBS LETTERS, 1991, 291 (01) :50-54
[4]
Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes [J].
Backer, Marina V. ;
Levashova, Zoya ;
Patel, Vimalkumar ;
Jehning, Brian T. ;
Claffey, Kevin ;
Blankenberg, Francis G. ;
Backer, Joseph M. .
NATURE MEDICINE, 2007, 13 (04) :504-509
[5]
Pharmacokinetics of the thymidine analog 2′-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats [J].
Bading, JR ;
Shahinian, AH ;
Vail, A ;
Bathija, P ;
Koszalka, GW ;
Koda, RT ;
Alauddin, MM ;
Fissekis, JD ;
Conti, PS .
NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (04) :407-418
[6]
Beer AJ, 2006, J NUCL MED, V47, P763
[7]
Beer AJ, 2005, J NUCL MED, V46, P1333
[8]
Comparison of integrin αvβ3 expression and glucose metabolism in primary and metastatic lesions in cancer patients:: A PET study using 18F-galacto-RGD and 18F-FDG [J].
Beer, Ambros J. ;
Lorenzen, Sylvie ;
Metz, Stephan ;
Herrmann, Ken ;
Watzlowikl, Petra ;
Wester, Hans-Juergen ;
Pesche, Christian ;
Lordick, Florian ;
Schwaiger, Markus .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (01) :22-29
[9]
[18F]Galacto-RGD positron emission tomography for imaging of αvβ3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck [J].
Beer, Ambros J. ;
Grosu, Anca-Ligia ;
Carlsen, Janette ;
Kolk, Andreas ;
Sarbia, Mario ;
Stangier, Isabelle ;
Watzlowik, Petra ;
Wester, Hans-Juergen ;
Haubner, Roland ;
Schwaiger, Markus .
CLINICAL CANCER RESEARCH, 2007, 13 (22) :6610-6616
[10]
Tumorigenesis and the angiogenic switch [J].
Bergers, G ;
Benjamin, LE .
NATURE REVIEWS CANCER, 2003, 3 (06) :401-410